L-carnitine supplementation decreases the left ventricular mass in patients undergoing hemodialysis

Circulation Journal

Volumn 72, Issue 6, 2008, Pages 926-931

  Sakurabayashi, Tai ^a   Miyazaki, Shigeru ^a   Yuasa, Yasuko ^a   Sakai, Shinji ^a   Suzuki, Masashi ^a   Takahashi, Sachio ^a   Hirasawa, Yoshihei ^a  

^a Kidney Ctr of Shinraku en Hospital   (Japan)

Author keywords

Carnitine; Hemodialysis; Left ventricular hypertrophy

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CALCIUM ANTAGONIST; CARNITINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROPOIETIN;

ANEMIA; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DYSLIPIDEMIA; ECHOCARDIOGRAPHY; FEMALE; HEART DISEASE; HEART FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEMATOCRIT; HEMODIALYSIS; HUMAN; MALE; SYSTOLE;

ADMINISTRATION, ORAL; ADULT; BLOOD PRESSURE; BODY WEIGHT; CARNITINE; ECHOCARDIOGRAPHY; FEMALE; HEMATOCRIT; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; TREATMENT OUTCOME; VITAMIN B COMPLEX;

EID: 45849103471     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.72.926     Document Type: Article

References (32)

1. Fritz IB. Carnitine and its role in fatty acid metabolism. Adv Lipid Res 1963; 1: 285-334.
2. Borum PR, Taggart EM. Carnitine nutriture of dialysis patients. J Am Diet Assoc 1986; 86: 644-647.
3. Opie LH. Role of carnitine in fatty acid metabolism of normal and ischemic myocardium. Am Heart J 1979; 97: 375-388.
4. Kelly DP, Strauss AW. Inherited cardiomyopathies. N Engl J Med 1994; 330: 913-919.
5. Nezu J, Tamai I, Oku A, Ohashi R, Yabuuchi H, Hashimoto N, et al. Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter. Nat Genet 1999; 21: 91-94.
6. Engel AG, Angelini C. Carnitine deficiency of human skeletal muscle with associated lipid storage myopathy: A new syndrome. Science 1973; 179: 899-902.
7. Bohmer T, Bergrem H, Eiklid K. Carnitine deficiency induced during intermittent hemodialysis for renal failure. Lancet 1978; 1: 126-128.
8. Ahmad S, Robertson HT, Golper TA, Wolfson M, Kurtin P, Katz LA, et al. Multicenter trial of L-camitine in maintenance hemodialysis patients. II: Clinical and biochemical effects. Kidney Int 1990; 38: 912-918.
9. Golper TA, Ahmad S. L-carnitine administration to hemodialysis patients: Has its time come? Semin Dial 1992; 5: 94-98.
10. Parfrey PS, Harnett JD, Barre PE. The natural history of myocardial disease in dialysis patients. J Am Soc Nephrol 1991; 2: 2-12.
11. Sakurabayashi T, Takaesu Y, Haginoshita S, Takeda T, Aoike I, Miyazaki S, et al. Improvement of myocardial fatty acid metabolism through L-carnitine administration to chronic hemodialysis patients. Am J Nephrol 1999; 19: 480-484.
12. Khoss AE, Steger H, Legenstein E, Proll E, Salzer-Muhar U, Schlemmer M, et al. L-carnitin therapie und Myokardfunktion bei chronisch haemodialysierten Kindern. Wien Klin Wochenschr 1989; 101: 17-20.
13. Van Es A, Henny FC, Kooistra MP, Lobatto S, Scholte HR. Amelioration of cardiac function by L-carnitine administration in patients on hemodialysis. Contrib Nephrol 1992; 98: 28-35.
14. Trovato GM, Iannetti E, Murgo AM, Carpinteri G, Catalano D. Body composition and long-term levo-carnitine supplementation. Clin Ter 1998; 149: 209-214.
15. Matsumoto Y, Sato M, Ohashi H, Araki H, Tadokoro M, Osumi Y, et al. Effects of L-carnitine supplementation on cardiac morbidity in hemodialyzed patients. Am J Nephrol 2000; 20: 201-207.
16. Fagher B, Cederblad G, Monti M, Olsson L, Rasmussen B, Thysell H. Carnitine and left ventricular function in hemodialysis patients. Scand J Clin Lab Invest 1985; 45: 193-198.
17. Silberberg JS, Barre PE, Pilchard SS, Sniderman AD. Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 1989; 36: 286-290.
18. Takahashi M, Ueda S, Misaki H, Sugiyama N, Matsumoto K, Matsuo N, et al. Carnitine determination by an enzymatic cycling method with carnitine dehydrogenase. Clin Chem 1994; 40: 817-821.
19. O'Rourke RA, Hanrath P, Henry WN, Hugenholtz PG, Pisa Z, Roelandt J, et al. Report of the joint International Society and Federation of Cardiology/World Health Organization task force: Recommendation for standardization of measurements from M-mode echocardiograms. Circulation 1984; 69: 854A-857A.
20. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al. Echocardiographic assessment of left ventricular hypertrophy: Comparisons to necropsy findings. Am J Cardiol 1986; 57: 450-458.
21. London GM, Marchais SJ, Guerin AP, Metivier F, Pannier B. Cardiac hypertrophy and arterial alterations in end-stage renal disease: Hemodynamic factors. Kidney Int 1993; 43(Suppl 41): S42-S49.
22. London GM, Fabiani F, Marchais SJ, de Vernejoul MC, Guerin AP, Safar ME, et al. Uremic cardiomyopathy: An inadequate left ventricular hypertrophy. Kidney Int 1987; 31: 973-980.
23. Harnett JD, Murphy B, Collingwood P, Purchase L, Kent G, Parfrey PS. The reliability and validity of echocardiographic measurement of left ventricular mass index in hemodialysis patients. Nephron 1993; 65: 212-214.
24. Dahan M, Siohan P, Viron B, Michel C, Paillole C, Gourgon R, et al. Relationship between left ventricular hypertrophy, myocardial contractility, and load conditions in hemodialysis patients: An echocardiographic study. Am J Kidney Dis 1997; 30: 780-785.
25. Paulson DJ. Carnitine deficiency-induced cardiomyopathy. Mol Cell Biochem 1998; 180: 33-41.
26. Fujibayashi Y, Yonekura Y, Tamaki N, Yamamoto K, Som P, Knapp FF Jr, et al. Myocardial accumulation of BMIPP in relation to ATP concentration. Ann Nucl Med 1993; 7(Suppl 2): 1-14.
27. Litwin SE, Raya TE, Gay RG, Bedotto JB, Bahl JJ, Anderson PG, et al. Chronic inhibition of fatty acid oxidation: New model of diastolic dysfunction. Am J Physiol 1990; 258: H51-H56.
28. Cannella G, La Canna G, Sandrini M, Gaggiotti M, Nordio G, Movilli E, et al. Reversal of left ventricular hypertrophy following recombinant human erythropoietin treatment of anaemic dialysed uraemic patients. Nephrol Dial Transplant 1991; 6: 31-37.
29. Ito S, Murai S, Sugiura M, Yoshida T, Fukutomi T. Predictors of congestive heart failure in patients on maintenance hemodialysis. Circ J 2007; 71: 1424-1429.
30. Washio M, Okuda S, Mizoue T, Kiyama S, Ando T, Sanai T, et al. Risk factors for left ventricular hypertrophy in chronic hemodialysis patients. Clin Nephrol 1997; 47: 362-366.
31. Kudoh Y, Shoji T, Oimatsu H, Yoshida S, Kikuchi K, Iimura O. The role of L-camitine in the pathogenesis of cardiomegaly in patients with chronic hemodialysis. Jpn Circ J 1983; 47: 1391-1397.
32. Zales VR, Benson DW Jr. Reversible cardiomyopathy due to carnitine deficiency from renal tubular waisting. Pediatr Cardiol 1995; 16: 76-78.